Lv41
680 积分 2021-07-22 加入
Real-world outcomes for 205 patients with chronic lymphocytic leukemia treated with ibrutinib
19天前
已完结
Treatment of Chronic Lymphocytic Leukemia
1个月前
已完结
How to Interpret the Results in a Noninferiority Randomized Trial in Chronic Lymphocytic Leukemia
3个月前
已关闭
MRD-driven treatment strategies in CLL: Current practice, limitations, and emerging paradigms
4个月前
已关闭
Rituximab, gemcitabine and oxaliplatin: An effective regimen in patients with refractory and relapsing mantle cell lymphoma
4个月前
已完结
Efficacy of the GemOx‐R regimen leads to the identification of Oxaliplatin as a highly effective drug against Mantle Cell Lymphoma
4个月前
已完结
Central nervous system involvement by mantle cell lymphoma
5个月前
已完结
New BTK Inhibitors May Combat Resistance in CLL
5个月前
已完结
Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b/2 study
5个月前
已完结
Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b/2 study
9个月前
已完结
皖公网安备34019202002308
